Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone deacetylase 1 (HDAC1) within the CoREST complex is a multi-protein epigenetic regulator consisting of the catalytic subunit HDAC1, the scaffolding protein REST corepressor 1 (RCOR1/CoREST), and the lysine-specific demethylase 1 (LSD1/KDM1A) [4, 10, 15]. This complex plays a pivotal role in silencing neuronal genes and regulating synaptic plasticity, making it a key target for treating neurodegenerative diseases like Alzheimer's [1, 2, 3]. In oncology, the complex is involved in maintaining the undifferentiated state of cancer cells and suppressing tumor suppressor genes in malignancies such as melanoma and leukemia [4, 10, 17]. Selective inhibitors, such as the Rodin series, target the HDAC activity specifically within the CoREST environment to improve safety profiles by reducing the hematological side effects typically associated with pan-HDAC inhibitors [1, 2]. Dual-action inhibitors like Corin target both the HDAC and LSD1 components of the complex to achieve synergistic anti-tumor effects [4, 11]. Overall, the HDAC1-CoREST complex serves as a critical node for integrating histone deacetylation and demethylation to control gene expression programs in health and disease [13, 15].
Inhibition of the catalytic activity of HDAC1 specifically when associated with the CoREST complex, leading to increased acetylation of histones (e.g., H3K9) and non-histone proteins, which restores the expression of silenced genes involved in synaptic function or tumor suppression.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone deacetylase 1 within the CoREST complex (HDAC1-CoREST complex).